Ph. Eur. General Notices Chapter - New Structure and Content

The European Pharmacopoeia (Ph. Eur.) Commission adopted a revised version of Ph. Eur. chapter 1. General Notices to provide greater clarity for users.

New structure and content

The revised Ph. Eur. chapter 1 General Notices features new additions such as

  • a section on monographs for medicinal products containing chemically defined APIs. This new section also provides information on related substances and impurities.
  • a sub-section on “Demonstration of suitability of monographs”.
  • a single section concerning monographs on herbal drugs, containing all paragraphs that were previously dispersed throughout the text.
  • an explanation of the rounding rule, information on chiral substances and an example of equivalents (in the tests and assay sections).
  • a clarification of the scope of first and second identification series and of alternative identifications.

In addition, the wording and terminology have been further harmonized. For example,

  • medicinal product” is selected instead of “finished product” and “pharmaceutical preparation”.
  • shelf life” and “re-test period” will be used instead of “period of use” and “period of validity”.

The revised Ph. Eur. chapter 1 General Notices will be published in Ph. Eur. Supplement 10.7, available in October 2021 (implementation date: 1 April 2022).

More information can be found in the EDQM Newsroom: Adoption of the revised General Notices chapter. 

Go back


Stay informed with the GMP Newsletters from ECA

GMP Newsletter

The ECA offers various free of charge GMP newsletters for which you can subscribe to according to your needs.

To subscribe, please click here.